by Clinical Neuropsychologist | Wednesday, March 26, 2025 | Dementia
Alzheimer’s &Dementia, Volume 21, Issue 3, March 2025. If you do not see content above, kindly GO TO SOURCE. Not all publishers encode content in a way that enables republishing at Neuro.vip. This post is Copyright: | March 26, 2025 Wiley-Online-Library:...
by Clinical Neuropsychologist | Wednesday, March 26, 2025 | Dementia
Abstract INTRODUCTION We aimed to determine whether cognitively unimpaired (CU) amyloid- beta-positive (Aβ+) individuals display decreased practice effects on serial neuropsychological testing. METHODS We included 209 CU participants from three research centers, 157...
by Clinical Neuropsychologist | Wednesday, March 26, 2025 | Dementia
Abstract INTRODUCTION Disturbances in microvascular flow dynamics are hypothesized to precede the symptomatic phase of Alzheimer’s disease (AD). However, evidence in presymptomatic AD remains elusive, underscoring the need for therapies targeting these early...
by Clinical Neuropsychologist | Thursday, March 20, 2025 | Dementia
Abstract INTRODUCTION Neighborhood disadvantage has been shown to impact health and cognitive outcomes, while morphological similarity network (MSN) can elucidate structural morphological patterns underlying cognitive functions. We hypothesized MSNs could provide...
by Clinical Neuropsychologist | Thursday, March 20, 2025 | Dementia
Abstract INTRODUCTION The presence of tau aggregates in and around the brain vasculature in Alzheimer’s disease (AD) and tauopathies suggests its possible pathogenicity to cerebral endothelial cells (ECs). METHODS We used an in vitro model of the blood–brain...
by Clinical Neuropsychologist | Thursday, March 20, 2025 | Dementia
Alzheimer’s &Dementia, Volume 21, Issue 3, March 2025. If you do not see content above, kindly GO TO SOURCE. Not all publishers encode content in a way that enables republishing at Neuro.vip. This post is Copyright: Lorenzo Pini, Bruno P Imbimbo | March 20,...
